Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Can Nonsterile Gloves for Dermatologic Procedures Be Cost-Effective without Compromising Infection Rates?

Kemp DM, Weingarten S, Chervoneva I, Marley W.

Skinmed. 2019 Sep 9;17(3):155-159. eCollection 2019.

PMID:
31496469
2.

A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.

Gonsalves CF, Eschelman DJ, Adamo RD, Anne PR, Orloff MM, Terai M, Hage AN, Yi M, Chervoneva I, Sato T.

Radiology. 2019 Oct;293(1):223-231. doi: 10.1148/radiol.2019190199. Epub 2019 Aug 27.

PMID:
31453767
3.

Disparities Among Cervical Cancer Patients Receiving Brachytherapy.

Bruce SF, Joshi TV, Chervoneva I, Yi M, Chatterjee-Paer S, Burton ER, Edelson MI, Sorosky JI, Shahin MS.

Obstet Gynecol. 2019 Sep;134(3):559-569. doi: 10.1097/AOG.0000000000003401.

PMID:
31403593
4.

In Vivo ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma.

Sanchez IM, Purwin TJ, Chervoneva I, Erkes DA, Nguyen MQ, Davies MA, Nathanson KL, Kemper K, Peeper DS, Aplin AE.

Mol Cancer Ther. 2019 Sep;18(9):1637-1648. doi: 10.1158/1535-7163.MCT-18-1056. Epub 2019 Jul 3.

PMID:
31270153
5.

N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease.

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB.

Clin Pharmacol Ther. 2019 Oct;106(4):884-890. doi: 10.1002/cpt.1548. Epub 2019 Jul 17.

PMID:
31206613
6.

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.

Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4.

PMID:
31165373
7.

The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.

Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE.

Pigment Cell Melanoma Res. 2019 Sep;32(5):687-696. doi: 10.1111/pcmr.12788. Epub 2019 May 20.

PMID:
31063649
8.

CADM1 is a TWIST1-regulated suppressor of invasion and survival.

Hartsough EJ, Weiss MB, Heilman SA, Purwin TJ, Kugel CH 3rd, Rosenbaum SR, Erkes DA, Tiago M, HooKim K, Chervoneva I, Aplin AE.

Cell Death Dis. 2019 Mar 25;10(4):281. doi: 10.1038/s41419-019-1515-3.

9.

Promoting mental health in traumatic brain injury using single-session Behavioural Activation and SMS messaging: A randomized controlled trial.

Hart T, Vaccaro M, Collier G, Chervoneva I, Fann JR.

Neuropsychol Rehabil. 2019 Mar 14:1-20. doi: 10.1080/09602011.2019.1592761. [Epub ahead of print]

PMID:
30870102
10.

Disparity in age at lung cancer diagnosis between current and former smokers.

Campling BG, Ye Z, Lai Y, Li L, Bar-Ad V, Werner-Wasik M, Lu B, Cowan SW, Evans NR, Chervoneva I, Wang C.

J Cancer Res Clin Oncol. 2019 May;145(5):1243-1251. doi: 10.1007/s00432-019-02875-6. Epub 2019 Mar 4.

PMID:
30830294
11.

The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides.

Hossain C, Jennings T, Duffy R, Knoblauch K, Gochoco A, Chervoneva I, Shi W, Alpdogan SO, Porcu P, Pro B, Sahu J.

Chin Clin Oncol. 2019 Feb;8(1):6. doi: 10.21037/cco.2018.10.02.

12.

BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.

Nikbakht N, Tiago M, Erkes DA, Chervoneva I, Aplin AE.

J Invest Dermatol. 2019 Jul;139(7):1612-1615. doi: 10.1016/j.jid.2018.12.024. Epub 2019 Jan 28. No abstract available.

PMID:
30703359
13.

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H.

Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.

PMID:
30528798
14.

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE.

Cancer Discov. 2018 Dec;8(12):1654. doi: 10.1158/2159-8290.CD-18-1291. No abstract available.

PMID:
30510016
15.

Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.

Mintzer S, Trinka E, Kraemer G, Chervoneva I, Werhahn KJ.

Epilepsia. 2018 Oct;59(10):1899-1907. doi: 10.1111/epi.14554. Epub 2018 Sep 3.

16.

ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.

Capparelli C, Purwin TJ, Heilman SA, Chervoneva I, McCue PA, Berger AC, Davies MA, Gershenwald JE, Krepler C, Aplin AE.

Cancer Res. 2018 Oct 1;78(19):5680-5693. doi: 10.1158/0008-5472.CAN-18-1001. Epub 2018 Aug 16.

17.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
18.

Visually validated semi-automatic high-frequency oscillation detection aides the delineation of epileptogenic regions during intra-operative electrocorticography.

Weiss SA, Berry B, Chervoneva I, Waldman Z, Guba J, Bower M, Kucewicz M, Brinkmann B, Kremen V, Khadjevand F, Varatharajah Y, Guragain H, Sharan A, Wu C, Staba R, Engel J Jr, Sperling M, Worrell G.

Clin Neurophysiol. 2018 Oct;129(10):2089-2098. doi: 10.1016/j.clinph.2018.06.030. Epub 2018 Jul 20.

PMID:
30077870
19.

Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers.

Bashir B, Stickle DF, Chervoneva I, Kraft WK.

Clin Transl Sci. 2018 Nov;11(6):590-596. doi: 10.1111/cts.12580. Epub 2018 Jul 27.

20.

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE.

Cancer Discov. 2018 May;8(5):568-581. doi: 10.1158/2159-8290.CD-17-0699. Epub 2018 Mar 1. Erratum in: Cancer Discov. 2018 Dec;8(12):1654.

21.

Extensions of D-optimal Minimal Designs for Symmetric Mixture Models.

Li Y, Raghavarao D, Chervoneva I.

Commun Stat Theory Methods. 2017;46(5):2542-2558. doi: 10.1080/03610926.2014.988258. Epub 2016 Feb 8.

22.

Changes in cerebellar functional connectivity and autonomic regulation in cancer patients treated with the Neuro Emotional Technique for traumatic stress symptoms.

Monti DA, Tobia A, Stoner M, Wintering N, Matthews M, Conklin CJ, Mohamed FB, Chervoneva I, Newberg AB.

J Cancer Surviv. 2018 Feb;12(1):145-153. doi: 10.1007/s11764-017-0653-9. Epub 2017 Oct 19.

PMID:
29052102
23.

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.

Hauzenberger JR, Hipszer BR, Loeum C, McCue PA, DeStefano M, Torjman MC, Kaner MT, Dinesen AR, Chervoneva I, Pieber TR, Joseph JI.

Diabetes Technol Ther. 2017 Nov;19(11):641-650. doi: 10.1089/dia.2017.0175. Epub 2017 Oct 5.

24.

Bimodal coupling of ripples and slower oscillations during sleep in patients with focal epilepsy.

Song I, Orosz I, Chervoneva I, Waldman ZJ, Fried I, Wu C, Sharan A, Salamon N, Gorniak R, Dewar S, Bragin A, Engel J Jr, Sperling MR, Staba R, Weiss SA.

Epilepsia. 2017 Nov;58(11):1972-1984. doi: 10.1111/epi.13912. Epub 2017 Sep 26.

25.

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.

Valsecchi ME, Orloff M, Sato R, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T.

Ophthalmology. 2018 Feb;125(2):210-217. doi: 10.1016/j.ophtha.2017.08.017. Epub 2017 Sep 19.

PMID:
28935400
26.

Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas.

Morita Y, Zhang R, Leslie M, Adhikari S, Hasan N, Chervoneva I, Rui H, Tanaka T.

Oncol Lett. 2017 Aug;14(2):2111-2118. doi: 10.3892/ol.2017.6466. Epub 2017 Jun 22.

27.

Effects of dextroamphetamine in subacute traumatic brain injury: A randomized, placebo-controlled pilot study.

Hart T, Whyte J, Watanabe T, Chervoneva I.

J Neurosci Res. 2018 Apr;96(4):702-710. doi: 10.1002/jnr.24102. Epub 2017 Jun 27.

PMID:
28653428
28.

Modeling qRT-PCR dynamics with application to cancer biomarker quantification.

Chervoneva I, Freydin B, Hyslop T, Waldman SA.

Stat Methods Med Res. 2018 Sep;27(9):2581-2595. doi: 10.1177/0962280216683204. Epub 2017 May 14.

29.

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.

Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME.

N Engl J Med. 2017 Jun 15;376(24):2341-2348. doi: 10.1056/NEJMoa1614835. Epub 2017 May 4.

30.

Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types.

Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I.

Nucleic Acids Res. 2017 Apr 7;45(6):2973-2985. doi: 10.1093/nar/gkx082.

31.

Neuro emotional technique effects on brain physiology in cancer patients with traumatic stress symptoms: preliminary findings.

Monti DA, Tobia A, Stoner M, Wintering N, Matthews M, He XS, Doucet G, Chervoneva I, Tracy JI, Newberg AB.

J Cancer Surviv. 2017 Aug;11(4):438-446. doi: 10.1007/s11764-017-0601-8. Epub 2017 Feb 8.

PMID:
28181091
32.

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22.

PMID:
27771841
33.

How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations.

Hart T, Whyte J, Poulsen I, Kristensen KS, Nordenbo AM, Chervoneva I, Vaccaro MJ.

Arch Phys Med Rehabil. 2016 Dec;97(12):2045-2053. doi: 10.1016/j.apmr.2016.07.012. Epub 2016 Aug 3.

PMID:
27497825
34.

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma.

Teh JL, Purwin TJ, Greenawalt EJ, Chervoneva I, Goldberg A, Davies MA, Aplin AE.

Cancer Res. 2016 Sep 15;76(18):5455-66. doi: 10.1158/0008-5472.CAN-15-3384. Epub 2016 Aug 3.

35.

RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms.

Yang J, Wu C, Stefanescu I, Jakobsson L, Chervoneva I, Horowitz A.

Sci Signal. 2016 Jul 26;9(438):ra76. doi: 10.1126/scisignal.aaf0791.

36.

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112. Epub 2016 Jun 17.

37.

Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers.

Nagalla S, Thomson L, Oppong Y, Bachman B, Chervoneva I, Kraft WK.

Clin Transl Sci. 2016 Jun;9(3):176-80. doi: 10.1111/cts.12398. Epub 2016 May 12.

38.

Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes.

Oppong YD, Farber JL, Chervoneva I, Martinez Cantarin MP.

Clin Transplant. 2016 Jul;30(7):836-44. doi: 10.1111/ctr.12757. Epub 2016 Jun 7.

PMID:
27146243
39.

Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.

Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, Sperling MR.

Epilepsy Behav. 2016 May;58:127-32. doi: 10.1016/j.yebeh.2016.02.023. Epub 2016 Apr 10.

40.

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.

Salem I, Alsalahi M, Chervoneva I, Aburto LD, Addya S, Ott GR, Ruggeri BA, Cristofanilli M, Fernandez SV.

Breast Cancer Res. 2016 Mar 24;18(1):37. doi: 10.1186/s13058-016-0694-4.

41.

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.

Terai M, Mu Z, Eschelman DJ, Gonsalves CF, Kageyama K, Chervoneva I, Orloff M, Weight R, Mastrangelo MJ, Cristofanilli M, Sato T.

EBioMedicine. 2015 Sep 18;2(11):1821-6. doi: 10.1016/j.ebiom.2015.09.019. eCollection 2015 Nov.

42.

Changes in the preferences of US physicians-in-training for medical interventions throughout medical education.

Valentino MA, Chervoneva I, Diemer GA.

Med Educ. 2016 Feb;50(2):214-24. doi: 10.1111/medu.12938.

PMID:
26813000
43.

Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury.

Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, Dreer LE, Kroenke K.

Arch Phys Med Rehabil. 2016 May;97(5):701-7. doi: 10.1016/j.apmr.2015.08.436. Epub 2015 Dec 18.

PMID:
26707456
44.

ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.

Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, Chervoneva I, Roszik J, Woodman SE, Davies MA, Setiady YY, Osman I, Yarden Y, Aplin AE.

Cancer Res. 2015 Sep 1;75(17):3554-67. doi: 10.1158/0008-5472.CAN-14-2959. Epub 2015 Jul 23.

45.

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Valsecchi ME, Terai M, Eschelman DJ, Gonsalves CF, Chervoneva I, Shields JA, Shields CL, Yamamoto A, Sullivan KL, Laudadio M, Berd D, Mastrangelo MJ, Sato T.

J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2. doi: 10.1016/j.jvir.2014.11.037. Epub 2015 Feb 9.

46.

A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK.

Am J Cancer Ther Pharmacol. 2014 Sep 7;2(1):21-32.

47.

A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.

Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N.

Biol Blood Marrow Transplant. 2015 Apr;21(4):646-52. doi: 10.1016/j.bbmt.2014.12.019. Epub 2014 Dec 23.

48.
49.

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.

Breast Cancer Res. 2013;15(5):R73.

50.

Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty.

Mraovic B, Hipszer BR, Epstein RH, Parvizi J, Pequignot EC, Chervoneva I, Joseph JI.

Croat Med J. 2013 Aug;54(4):355-61.

Supplemental Content

Loading ...
Support Center